Estados financieros detallados de PMGC Holdings Inc. (ELAB): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 10.3%, margen operativo -477.0%, margen neto -5.2%.
Al precio actual de $4.77, ELAB presenta beneficios negativos (P/E no significativo) y un ROE del -98.35%. La capitalización bursátil es de $2M.
Cuenta de Resultados (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | $827 | $766277 | 0 | $2.5M | $590084 |
| Coste de Ventas | 0 | $88 | $318968 | $554 | $670197 | $515273 |
| Beneficio Bruto | 0 | $739 | $447309 | -$554 | $1.8M | $74811 |
| I+D | $118857 | $123632 | $228747 | $7410 | $104654 | $147010 |
| Generales y Administrativos | $102987 | $634334 | $1.7M | $1.1M | $855764 | $1.6M |
| Gastos Operativos | $221844 | $785801 | $2.2M | $1.1M | $3.7M | $7.5M |
| Beneficio Operativo | -$221844 | -$785062 | -$1.8M | -$1.1M | -$1.9M | -$7.4M |
| EBITDA | 0 | -$781982 | -$1.8M | -$1.1M | -$3.2M | -$7.3M |
| Gastos por Intereses | 0 | 0 | $2629 | 0 | $735197 | $547128 |
| Beneficio Antes de Impuestos | -$222910 | -$784739 | -$1.8M | -$1.7M | -$4.0M | -$7.7M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | $30972 |
| Beneficio Neto | -$222910 | -$784739 | -$1.8M | -$4.3M | -$6.2M | -$7.7M |
| BPA | $-19.79 | $-887.71 | $-158.40 | $-477946.33 | $-65923.20 | $-3787.40 |
| BPA Diluido | $-19.79 | $-887.71 | $-158.40 | $-1511.43 | $-65923.20 | $-3787.40 |
| Acciones en Circulación (Diluidas) | $11263 | $884 | $11344 | $2846 | $95 | $2035 |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $285948 | $304136 | $681994 | $1.3M |
| Beneficio Bruto | $42746 | $47528 | $71030 | $104454 |
| Beneficio Operativo | -$2.2M | -$3.0M | -$3.3M | -$3.8M |
| EBITDA | -$2.4M | -$2.9M | -$3.2M | -$3.5M |
| Beneficio Neto | -$2.6M | -$3.0M | -$5.0M | -$2.9M |
| BPA | $-1178.40 | $-519.20 | $-111.70 | $-6.00 |
| BPA Diluido | $-1178.40 | $-519.20 | $-111.70 | $-6.00 |
Balance (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $13351 | $411858 | $1.2M | $3.3M | $4.0M | $5.4M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $371 | $1710 | $12854 | $36161 | $5276 | $340531 |
| Inventario | 0 | $160817 | $230145 | $495667 | $1044 | $95098 |
| Activos Corrientes | $17022 | $636525 | $1.6M | $4.9M | $6.1M | $6.9M |
| Inmovilizado Material | 0 | $29725 | $330088 | $1741 | $1087 | $2.1M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | $977774 |
| Activos Intangibles | 0 | 0 | 0 | 0 | $2.8M | $2.9M |
| Activos Totales | $17022 | $666250 | $1.9M | $5.2M | $9.0M | $12.9M |
| Cuentas por Pagar | $154 | $98175 | $210840 | $596147 | $481000 | $697633 |
| Deuda a Corto | $24000 | 0 | 0 | 0 | 0 | $1.3M |
| Pasivos Corrientes | $40611 | $215622 | $588272 | $1.3M | $1.8M | $3.9M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | $1.1M |
| Pasivos Totales | $40611 | $215622 | $760873 | $1.4M | $2.3M | $5.0M |
| Reservas | -$137366 | -$922105 | -$2.7M | -$7.0M | -$13.3M | -$21.0M |
| Patrimonio Neto | -$23589 | $450628 | $1.1M | $3.8M | $6.7M | $7.8M |
| Deuda Total | $24000 | 0 | $283217 | $210489 | 0 | $2.6M |
| Deuda Neta | $10649 | -$411858 | -$871684 | -$3.1M | -$4.0M | -$2.8M |
| Capital Circulante | -$23589 | $420903 | $963050 | $3.6M | $4.3M | $2.9M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $7.7M | $5.4M | $14.4M | $18.1M |
| Activos Totales | $14.9M | $12.9M | $26.0M | $36.6M |
| Pasivos Totales | $6.4M | $5.0M | $13.4M | $19.8M |
| Patrimonio Neto | $8.5M | $7.8M | $12.6M | $16.7M |
| Deuda Total | $5.4M | $2.6M | $8.0M | $13.9M |
Flujo de Caja (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$222910 | -$784739 | -$1.8M | -$4.3M | -$6.2M | -$7.7M |
| Amortizaciones | 0 | $2757 | $6512 | $11649 | $12950 | $96663 |
| Compensación en Acciones | 0 | $142355 | $171869 | $487738 | $97167 | -$19160 |
| Cambio en Capital Circulante | $6787 | -$21907 | $12433 | -$823190 | $251666 | $588120 |
| Flujo de Caja Operativo | -$217164 | -$660934 | -$1.6M | -$4.6M | -$5.5M | -$5.9M |
| Inversiones (CapEx) | 0 | -$32482 | -$35527 | -$11191 | -$9160 | -$448255 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | -$2.2M |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | -$179 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$217164 | -$693416 | -$1.6M | -$4.6M | -$5.5M | -$6.4M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$1.5M | -$1.8M | -$3.0M | -$2.0M |
| Inversiones (CapEx) | -$95594 | -$346661 | -$363085 | $27569 |
| Flujo de Caja Libre | -$1.6M | -$2.1M | -$3.3M | -$2.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $13179 | $10657 | -$23836 | $174545 |
Crecimiento y Márgenes (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | +92557.4% | -100.0% | | -76.1% |
| Crecimiento Beneficio Neto (anual) | | -252.0% | -129.4% | -138.9% | -45.2% | -23.4% |
| Crecimiento BPA (anual) | | -4385.6% | +82.2% | -301633.8% | +86.2% | +94.3% |
| Cambio en Acciones (anual) | | -92.2% | +1183.3% | -74.9% | -96.7% | +2042.1% |
| Crecimiento FCF (anual) | | -219.3% | -133.8% | -181.7% | -20.1% | -16.3% |
| Margen Bruto | | 89.4% | 58.4% | | 72.8% | 12.7% |
| Margen Operativo | | -94928.9% | -233.4% | | -75.7% | -1250.1% |
| Margen EBITDA | | -94556.5% | -233.7% | | -129.6% | -1231.4% |
| Margen Neto | | -94889.8% | -234.9% | | -253.1% | -1306.3% |
| Margen FCF | | -83847.2% | -211.6% | | -222.4% | -1081.6% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.4% |
Datos por Acción (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-19.28 | $-784.41 | $-142.93 | $-1605.06 | $-57757.68 | $-3136.18 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $11263 | $884 | $11344 | $9 | $95 | $2035 |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -98.35% |
| Rentabilidad sobre capital invertido | -70.17% |
| Rentabilidad sobre activos | -59.90% |
| Margen bruto | 10.31% |
| Margen operativo | -477.02% |
| Margen neto | -522.97% |
Salud financiera
| Deuda / Patrimonio | 0.83 |
| Ratio corriente | 1.36 |
Ratios Clave (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -808165.74 | -18016.69 | -100969.70 | -17.99 | -0.82 | -0.38 |
| P/VC | -7636437.19 | 31374.75 | 160372.84 | 20.22 | 0.77 | 0.37 |
| P/V | 0.00 | 17095940.02 | 236769.99 | 0.00 | 2.07 | 4.90 |
| Margen Bruto | 0.0% | 89.4% | 58.4% | 0.0% | 72.8% | 12.7% |
| Margen Operativo | 0.0% | -94928.9% | -233.4% | 0.0% | -75.7% | -1250.1% |
| Margen Neto | 0.0% | -94889.8% | -234.9% | 0.0% | -253.1% | -1306.3% |